Quick Answer
ZEVRA THERAPEUTICS, INC. reported Stockholders Equity of $154.66 million for the year ending 2025.
- ZEVRA THERAPEUTICS, INC. showed an increase of +289.9% in Stockholders Equity from 2024 to 2025.
- This data is from ZEVRA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$54.35 million | Q2 2015: $3.46 million | Q3 2015: -$5.75 million | Q1 2016: -$11.48 million | Q2 2016: $333.0 thousand | Q3 2016: -$9.80 million | Q1 2017: -$33.93 million | Q2 2017: -$39.28 million | Q3 2017: -$48.10 million | Q1 2018: -$79.68 million | Q2 2018: -$83.55 million | Q3 2018: -$95.35 million | Q1 2019: -$74.84 million | Q2 2019: -$81.55 million | Q3 2019: -$70.62 million | Q1 2020: -$68.68 million | Q2 2020: -$62.86 million | Q3 2020: -$62.33 million | Q1 2021: $84.25 million | Q2 2021: $130.66 million | Q3 2021: $131.74 million | Q1 2022: $121.50 million | Q2 2022: $99.23 million | Q3 2022: $93.79 million | Q1 2023: $59.27 million | Q2 2023: $58.87 million | Q3 2023: $61.52 million | Q1 2024: $48.82 million | Q2 2024: $32.48 million | Q3 2024: $69.77 million | Q1 2025: $41.02 million | Q2 2025: $117.23 million | Q3 2025: $133.17 million.
- Over the full 15 years of available data (2012 to 2025), ZEVRA THERAPEUTICS, INC.'s Stockholders Equity has grown by 906.6%.
- Historical annual values: Fiscal year 2025: $154.66 million | Fiscal year 2024: $39.67 million | Fiscal year 2023: $61.86 million | Fiscal year 2023: $61.52 million | Fiscal year 2022: $75.12 million | Fiscal year 2021: $101.66 million | Fiscal year 2020: -$66.41 million | Fiscal year 2019: -$74.46 million | Fiscal year 2018: -$66.57 million | Fiscal year 2017: -$57.52 million | Fiscal year 2016: -$18.70 million | Fiscal year 2015: -$10.12 million | Fiscal year 2014: -$48.51 million | Fiscal year 2013: -$24.27 million | Fiscal year 2012: -$19.18 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: